ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2022

Correction to: Effectiveness in Real World of Once Weekly Semaglutide in People with Type 2 Diabetes: Glucagon-Like Peptide Receptor Agonist Naïve or Switchers from Other Glucagon-Like Peptide Receptor Agonists: Results from a Retrospective Observational Study in Umbria.

Chiara Di Loreto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.